Original Article

Early Menopause and Risk of Fractures–A Preventable Gap

Abstract

Background: Osteoporosis is a chronic disease that results in microarchitectural changes to the bone, thereby reducing its density and increasing the risk of fractures. This retrospective cross-sectional study aimed to examine the link between the risk of major osteoporotic fractures and hip fractures with the age of menopause onset, as well as the impact of menopause duration on fracture incidence.

Methods: This retrospective cross-sectional study was conducted at the Special Hospital for Rheumatic Diseases, Novi Sad, Serbia. The data required for meeting the study objectives were obtained from patients’ medical records spanning the 2015-2018 period. The sample for the study comprised of 985 postmenopausal women aged ≥ 50 yr who underwent bone mineral densitometry examination and received a FRAX score for major osteoporotic fractures and hip fractures with and without bone mineral density. The obtained FRAX scores were compared across the subjects with respect to the age of menopause onset and menopause duration.

Results: The group that entered into menopause before the age of 45 had a high risk of hip fracture (OR: 1,652; 95% CI: 1,138 - 2,399; P<.01) and a higher mean FRAX score for hip fracture compared to women in whom menopause started after the age of 45 (Me=1.60 vs. 1.30, P<.004). FRAX scores were also correlated with menopause duration, and the difference between the groups with the longest (over 20 yr) and the shortest (1–10 yr) duration was statistically significant at P<.001.

Conclusion: As menopause duration could contribute to the prediction of fracture risk, its inclusion in the FRAX algorithm should be considered, while also taking into account the age of menopause onset.

 

1. Bougioukli S, Κollia P, Koromila T, et al (2019). Failure in diagnosis and under-treatment of osteoporosis in elderly patients with fragility fractures. J Bone Miner Metab, 37 (2): 327-35.
2. Kanis JA, Cooper C, Rizzoli R, et al (2019). European guidance for the diagnosis and management of osteoporosis in postmeno-pausal women. Osteoporos Int, 30 (1): 3-44.
3. Cavalli L, Guazzini A, Cianferotti L, et al (2016). Prevalence of osteoporosis in the Ital-ian population and main risk factors: results of BoneTour Campaign. BMC Musculoskelet Disord, 17 (1): 396.
4. Zhu SY, Deng Y, Wang YF, et al (2019). Bone protection for early menopausal women in China: standard or half-dose estrogen with progestin? A one-year prospective random-ized trail. Gynecol Endocrinol, 35 (2): 165-9.
5. Møller AMJ, Delaissé JM, Olesen JB, et al (2020). Aging and menopause reprogram os-teoclast precursors for aggressive bone re-sorption. Bone Res, 8: 27.
6. Mottaghi P, Nasri P (2021). Antioxidant and Bone; Protect Your Future: A Brief Review. Iran J Public Health, 50 (9): 1783-8.
7. Vuksanović M, Beljić-Živković T (2016). Cap-ture the fracture – Use of bone turnover markers in clinical practice. Srp Arh Celok Lek, 144 (7-8): 450-5.
8. Anagnostis P, Siolos P, Gkekas NK, et al (2019). Association between age at meno-pause and fracture risk: a systematic review and meta-analysis. Endocrine, 63 (2) :213-24.
9. Yang DH, Yang MY (2019). The Role of Macrophage in the Pathogenesis of Osteopo-rosis. Int J Mol Sci, 20 (9): 2093.
10. Ilic Stojanovic O, Vuceljic M, Lazovic M, et al (2017). Bone mineral density at different sites and vertebral fractures in Serbian postmeno-pausal women. Climacteric, 20 (1): 37-43.
11. Kanis JA, Johansson H, Harvey NC, et al (2018). A brief history of FRAX. Arch Osteopo-ros, 13 (1):118.
12. Rodgers RJ, Laven JS (2020). Genetic rela-tionships between early menopause and the behaviour of theca interna during follicular atresia. Hum Reprod, 35 (10): 2185-7.
13. Golezar S, Ramezani Tehrani F, Khazaei, et al (2019). The global prevalence of primary ovarian insufficiency and early menopause: a meta-analysis. Climacteric, 22 (4): 403-11.
14. Centre for Metabolic Bone Diseases, Univer-sity of Sheffield, UK. Available at: https://www.sheffield.ac.uk/FRAX/tool.aspx?lang=srb [Accessed February 2021]
15. Khosla S (2019). Personalising osteoporosis treatment for patients at high risk of fracture. Lancet Diabetes Endocrinol, 7 (10): 739-41.
16. Rakić JG, Maksimović M, Janković J, et al (2018). Relationship between socioeconomic and nutritional status in the Serbian adult population: a cross-sectional study. Sao Paulo Med J, 136 (4): 310-8.
17. Maksimović MŽ, Gudelj Rakić JM, Vlajinac HD, et al (2013). Comparison of different an-thropometric measures in the adult popula-tion in Serbia as indicators of obesity: data from the National Health Survey 2013. Public Health Nutr, 19 (12): 2246-55.
18. Francucci CM, Romagni P, Camilletti A, et al (2008). Effect of natural early menopause on bone mineral density. Maturitas, 59 (4): 323-8.
19. Sullivan SD, Lehman A, Thomas F, et al (2015). Effects of self-reported age at non-surgical menopause on time to first fracture and bone mineral density in the Womenʼs Health Initiative Observational Study. Meno-pause, 22 (10): 1035-44.
20. Ramírez-Pérez E, Clark P, Barredo-Prieto B, et al (2019). Estimation of absolute risk of frac-ture due to fragility in Mexican women with early and natural menopause. Cir Cir, 87 (3): 260-266.
21. Sullivan SD, Lehman A, Nathan NK, et al (2017). Age of menopause and fracture risk in postmenopausal women randomized to calci-um + vitamin D, hormone therapy, or the combination. Menopause, 24 (4): 371-378.
22. Chen FP, Hsu KH, Fu TS, et al (2016). Risk factor for first-incident hip fracture in Tai-wanese postmenopausal women. Taiwan J Ob-stet Gynecol, 55 (2): 258-62.
23. Shin CS, Kim MJ, Shim SM, et al (2012). The prevalence and risk factors of vertebral frac-tures in Korea. J Bone Miner Metab, 30 (2): 183-92.
24. Banks E, Reeves GK, Beral V, et al (2009). Hip Fracture Incidence in Relation to Age, Menopausal Status, and Age at Menopause: Prospective Analysis. PLoS Med, 6(11): e1000181.
25. Peng K, Yao P, Kartsonaki C, et al (2020). Menopause and risk of hip fracture in mid-dle-aged Chinese women. Menopause, 27 (3): 311–8.
26. El Maataoui A, El Maghraoui A, Biaz A, et al (2015). Relationships between vertebral frac-tures, sex hormones and vitamin D in Mo-roccan postmenopausal women: a cross sec-tional study. BMC Womens Health, 15: 41.
27. Nguyen HH, Wong P, Strauss BJ, et al (2017). Delay in estrogen commencement is associat-ed with lower bone mineral density in Turner syndrome. Climacteric, 20 (5): 436-441.
28. Fistarol M, Rezende CR, Figueiredo Campos AL, et al (2019). Time since menopause, but not age, is associated with increased risk of osteoporosis. Climacteric, 22 (5): 523-526.
29. Silva TR, Franz R, Maturana MA, et al (2015). Association between body composition and lifestyle factors with bone mineral density ac-cording to time since menopause in women from southern Brazil: a cross-sectional study. BMC Endocr Disord, 15: 71.
Files
IssueVol 52 No 3 (2023) QRcode
SectionOriginal Article(s)
DOI https://doi.org/10.18502/ijph.v52i3.12136
Keywords
Menopause Duration of menopause Fracture risk assessment tool Osteoporosis Fracture risk
Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
1.
Minakovic I, Zvekic-Svorcan J, Jankovic T, Vuksanovic M, Mikic D, Boskovic K. Early Menopause and Risk of Fractures–A Preventable Gap. Iran J Public Health. 2023;52(3):534-541.